Harbour BioMed inks collaboration with AstraZeneca to discover and develop next-generation therapeutic antibodies
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in immunology and oncology, announced a global strategic collaboration with AstraZeneca to discover and develop …